Monaco, M.L.; Filpi, G.A.; Kohler, S.L.; Eversole, R.; Idris, O.A.; Essani, K.
Oncolytic Tanapoxvirus Recombinants Expressing Flagellin C or Mouse Interleukin-2 Are Capable of Regressing Human Triple-Negative Breast Cancer Xenografts in Immuno-Competent BALB/c Nude Mice. Pathogens 2024, 13, 402.
https://doi.org/10.3390/pathogens13050402
AMA Style
Monaco ML, Filpi GA, Kohler SL, Eversole R, Idris OA, Essani K.
Oncolytic Tanapoxvirus Recombinants Expressing Flagellin C or Mouse Interleukin-2 Are Capable of Regressing Human Triple-Negative Breast Cancer Xenografts in Immuno-Competent BALB/c Nude Mice. Pathogens. 2024; 13(5):402.
https://doi.org/10.3390/pathogens13050402
Chicago/Turabian Style
Monaco, Michael L., Grace A. Filpi, Steven L. Kohler, Robert Eversole, Omer A. Idris, and Karim Essani.
2024. "Oncolytic Tanapoxvirus Recombinants Expressing Flagellin C or Mouse Interleukin-2 Are Capable of Regressing Human Triple-Negative Breast Cancer Xenografts in Immuno-Competent BALB/c Nude Mice" Pathogens 13, no. 5: 402.
https://doi.org/10.3390/pathogens13050402
APA Style
Monaco, M. L., Filpi, G. A., Kohler, S. L., Eversole, R., Idris, O. A., & Essani, K.
(2024). Oncolytic Tanapoxvirus Recombinants Expressing Flagellin C or Mouse Interleukin-2 Are Capable of Regressing Human Triple-Negative Breast Cancer Xenografts in Immuno-Competent BALB/c Nude Mice. Pathogens, 13(5), 402.
https://doi.org/10.3390/pathogens13050402